CSIMarket
 


Corbus Pharmaceuticals Holdings Inc   (CRBP)
Other Ticker:  
 
 

CRBP's Gross Income Growth by Quarter and Year

Corbus Pharmaceuticals Holdings Inc 's Gross Income results by quarter and year




CRBP Gross Income (in millions $) FY 2023 FY 2022 FY 2021 FY 2020
IV Quarter December - 0.00 0.00 0.66
III Quarter September 0.00 0.00 0.10 1.23
II Quarter June 0.00 0.00 0.14 0.29
I Quarter March 0.00 0.00 0.65 1.76
FY   0.00 0.00 0.89 3.94



CRBP Gross Income third quarter 2023 Y/Y Growth Comment
Corbus Pharmaceuticals Holdings Inc in the third quarter 2023 recorded Gross Loss of $ 0.00 millions.

According to the results reported in the third quarter 2023, Corbus Pharmaceuticals Holdings Inc achieved the best Gross Income growth in Major Pharmaceutical Preparations industry. While Corbus Pharmaceuticals Holdings Inc ' s Gross Income no change of % ranks overall at the positon no. in the third quarter 2023.

Explain Gross Income Margin


CRBP Gross Income ( Y/Y Growth %) 2023
2022 2021 2020
IV Quarter December - - - -74.32 %
III Quarter September - - -91.87 % -52.51 %
II Quarter June - - -51.72 % -99 %
I Quarter March - - -63.07 % -6.88 %
FY   - - -77.41 % -89.1 %

Financial Statements
Corbus Pharmaceuticals Holdings Inc 's third quarter 2023 Gross Income $ 0.00 millions CRBP's Income Statement
Corbus Pharmaceuticals Holdings Inc 's third quarter 2022 Gross Income $ 0.00 millions Quarterly CRBP's Income Statement
New: More CRBP's historic Gross Income Growth >>


CRBP Gross Income (Quarter on Quarter Growth %)

2023
2022 2021 2020
IV Quarter December - - - -46.34 %
III Quarter September - - -28.57 % 324.14 %
II Quarter June - - -78.46 % -83.52 %
I Quarter March - - -1.52 % -31.52 %
FY (Year on Year)   - - -77.41 % -89.1 %




Gross Income third quarter 2023 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Gross Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Gross Income third quarter 2023 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Gross Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Gross Income by Quarter for the Fiscal Years 2020, 2021, 2022, 2023

Corbus Pharmaceuticals Holdings Inc 's Q/Q Gross Income Growth


Gross Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


CRBP's III. Quarter Q/Q Gross Income Comment


Gross Income Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Gross Income Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Gross Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


CRBP's III. Quarter Q/Q Gross Income Comment


Corbus Pharmaceuticals Holdings Inc 's 12 Months Gross Income Growth Year on Year


Gross Income TTM Growth

12 Months Ending
(Sep 30 2023)
12 Months Ending
(Jun 30 2023)
12 Months Ending
(Mar 31 2023)
12 Months Ending
(Dec 31 2022)
12 Months Ending
(Sep 30 2022)
Cumulative Gross Income 12 Months Ending $ 0.00 $ 0.00 $ 0.00 $ 0.00 $ 0.00
Y / Y Gross Income Growth (TTM) - - - - -
Year on Year Gross Income Growth Overall Ranking # # # # #
Seqeuential Gross Income Change (TTM) - - - - -
Seq. Gross Income Growth (TTM) Overall Ranking # # # # #




Cumulative Gross Income growth Comment
In the Sep 30 2023 period, Corbus Pharmaceuticals Holdings Inc 's cumulative trailing twelve month Gross Income remained unchanged compare to the same period a year ago.

Corbus Pharmaceuticals Holdings Inc achieved highest trailing twelve month year on year Gross Income growth. While overall Gross Income growth ranking, remained unchanged compare to the previous quarter at no. .

Gross Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Gross Income TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Gross Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Gross Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Gross Income growth Comment
In the Sep 30 2023 period, Corbus Pharmaceuticals Holdings Inc 's cumulative trailing twelve month Gross Income remained unchanged compare to the same period a year ago.

Corbus Pharmaceuticals Holdings Inc achieved highest trailing twelve month year on year Gross Income growth. While overall Gross Income growth ranking, remained unchanged compare to the previous quarter at no. .

Gross Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Gross Income TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Gross Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Gross Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Gross Income Growth
Major Pharmaceutical Preparations Industry Gross Income Growth Trends and Statistics
Healthcare Sector Gross Income Growth Statistics
Gross Income Growth Trends for overall market
CRBP's Gross Income Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Gross Income Growth
Lowest Ranking Gross Income Growth
Gross Income Growth for CRBP's Competitors
Gross Income Growth for Corbus Pharmaceuticals Holdings Inc 's Suppliers
Gross Income Growth for CRBP's Customers

You may also want to know
CRBP's Annual Growth Rates CRBP's Profitability Ratios CRBP's Asset Turnover Ratio CRBP's Dividend Growth
CRBP's Roe CRBP's Valuation Ratios CRBP's Financial Strength Ratios CRBP's Dividend Payout Ratio
CRBP's Roa CRBP's Inventory Turnover Ratio CRBP's Growth Rates CRBP's Dividend Comparisons



Companies with similar Gross Income no change for the quarter ending Sep 30 2023 within Healthcare SectorY/Y Change %Gross Income for the quarter ending Sep 30 2023
Karyopharm Therapeutics Inc -0.19%$ -0.191 millions
Halozyme Therapeutics Inc -0.28%$ -0.277 millions
Envista Holdings Corporation-0.38%$ -0.384 millions
Healthlynked Corp -0.39%$ -0.386 millions
Prestige Consumer Healthcare Inc -0.61%$ -0.614 millions
Bellicum Pharmaceuticals Inc -0.89%$ -0.890 millions
Ispecimen inc -1.19%$ -1.187 millions
Icu Medical Inc-1.33%$ -1.328 millions
Phibro Animal Health Corporation-1.34%$ -1.340 millions
Baxter International Inc -1.41%$ -1.412 millions
Lifevantage Corp-1.55%$ -1.549 millions
Optinose Inc -1.98%$ -1.977 millions
Dentsply Sirona Inc -2.56%$ -2.559 millions
Hologic Inc-2.80%$ -2.798 millions
Celularity Inc -2.83%$ -2.829 millions
Gilead Sciences Inc -2.85%$ -2.851 millions
Akumin Inc -3.21%$ -3.205 millions
Viatris Inc -3.27%$ -3.266 millions
Syros Pharmaceuticals Inc -3.32%$ -3.315 millions
Royalty Pharma Plc-3.44%$ -3.437 millions
Standard Biotools Inc -3.47%$ -3.470 millions
Vaso Corporation-3.93%$ -3.933 millions
Puma Biotechnology Inc -3.98%$ -3.979 millions
Orasure Technologies Inc-4.01%$ -4.009 millions
3m Company-4.09%$ -4.086 millions
Abbott Laboratories-4.20%$ -4.203 millions
Charles River Laboratories International inc -4.23%$ -4.229 millions
Mettler toledo International Inc -4.30%$ -4.296 millions
Bristol myers Squibb Company-4.57%$ -4.569 millions
Twist Bioscience Corporation-4.66%$ -4.662 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com